You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 3, March 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Invited Critique
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Surgical Physiology, Other
 •Diagnosis
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Alert me on articles by topic

B-Type Natriuretic Peptide: A Biomarker for the Diagnosis and Risk Stratification of Patients With Septic Shock—Invited Critique

Eddie L. Hoover, MD

Arch Surg. 2008;143(3):246.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Kandil and colleagues purport a role for BNP level as a useful marker of ventricular function and mortality in sepsis. There were no demographic data provided for the groups, specifically age and the underlying disease. Also, the absence of any BNP data between days 1 and 21 precludes potential useful information about BNP activity in response to therapy. These investigators state that patients without renal and heart failure may benefit from measurement of BNP levels but do not present any supporting data, only concepts. They also state that BNP level determination may help with risk stratification, which is suspect because there was no significant difference between the control subjects and patients with early sepsis (100 ± 9.4 vs 120 ± 11.2 pg/mL). They further stated that BNP level may serve as "a valuable measure for determining reduced left ventricular function in patients with septic shock"; again, with no supporting data. . . . [Full Text of this Article]


AUTHOR INFORMATION

RELATED ARTICLE

B-Type Natriuretic Peptide: A Biomarker for the Diagnosis and Risk Stratification of Patients With Septic Shock
Emad Kandil, Joshua Burack, Ahmed Sawas, Haidy Bibawy, Alex Schwartzman, Michael E. Zenilman, and Martin H. Bluth
Arch Surg. 2008;143(3):242-246.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.